- Home >
- Life Sciences >
- Pharmaceutical >
MarketWatch: Cancer
MarketWatch: Cancer
- Report price : $ 200
- Publication date : July 2008
- Length : 28 pages
MarketWatch: Cancer
Datamonitor's Cancer MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the cancer therapeutic area. MarketWatch features all the major current business issues and events, including R&D news, licensing deals, alliances and joint ventures, and regulatory decisions.
RELATED REPORTS
MarketWatch: Health Round-up
- $ 400
- July 2008
- 48 pages
Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Healthcare industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory an ...
Industries : Pharmaceutical
Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
- $ 15 400
- July 2008
- 161 pages
IntroductionVaccines have re-emerged as successful revenue generators for Big Pharma, with adults and the elderly now increasingly coming into focus as the next big opportunity in this sector. An aging population, rising disease awareness and new technologies to overcome the scientific hurdles linke ...
Industries : Pharmaceutical
Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma
- $ 15 200
- July 2008
- 235 pages
IntroductionAsthma is managed using a step-wise approach, with bronchodilators to relieve symptoms of airflow limitation and controller medications to target underlying inflammation. Datamonitor's research shows that almost all patients (even those with mild intermittent asthma) receive some type of ...
Industries : Pharmaceutical
Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
- $ 15 200
- July 2008
- 193 pages
IntroductionWith a considerable patient potential and large medical unmet need, the untapped fibromyalgia market represents a lucrative opportunity for pharmaceutical companies. Estimated to total around $650m in 2007 in the seven major markets, Datamonitor forecasts the market to grow to over $2.4 ...
Industries : Pharmaceutical
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
- $ 7 600
- July 2008
- 162 pages
IntroductionAt the forefront of novel technologies; momentum is steadily building for the development of stem cell products to address cardiovascular disease. The most active areas are those with high clinical unmet need heart failure, cardiomyopathy and ishemic heart disease.Scope*Analysis of the ...
Industries : Pharmaceutical
MarketWatch: CNS
- $ 200
- July 2008
- 25 pages
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives. It provides monthly insight into the key events in the CNS industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory and licensing in theCN ...
Industries : Pharmaceutical
MarketWatch: Biotechnology
- $ 200
- July 2008
- 32 pages
Datamonitor's Biotechnology MarketWatch is a one-stop news shop for time-pressed executives. It provides monthly insight into the key events in the Biotechnology industry. The report contains the latest news, analysis and opinion, covering all the month's major issues and events in R&D, regulatory a ...
Industries : Pharmaceutical
PharmaVitae: Company Comparator Tool
- $ 45 600
- June 2008
IntroductionThe Comparator Tool builds from the PharmaVitae profiles of the 50 leading pharma companies. Updated monthly, the tool allows you to compare the 50 players by current and forecast sales to 2012.Reasons to Purchase*Compare players by US or global forecast therapy area sales and portfolio ...
Industries : Pharmaceutical
US Enzymes Market
- $ 4 600
- June 2008
US demand to grow 6% annually through 2012US demand for enzymes will rise nearly six percent per year to $2.5 billion in 2012. Advances will be led by continued rapid expansion in the fuel ethanol enzyme market, as well as strong growth in the large pharmaceutical and smaller biocatalyst and pulp an ...
Industries : Pharmaceutical
Booming Pharma Sector in India
- $ 1 300
- January 2008
India, a US$ 8.2 Billion pharmaceutical market, represents one of the most emerging pharmaceutical markets in the world. According to the RNCOS latest report “Booming Pharma Sector in India”, in near future, the potential and opportunities within this market will increase by several folds. The m ...
Industries : Pharmaceutical
Related industries
reportlinker.com © Copyright 2009. All rights reserved